放大器
免疫球蛋白轻链
分子生物学
DNA测序
DNA
生物
聚合酶链反应
杂交探针
抗体
计算生物学
基因
遗传学
作者
Neelam Chaudhary,Louis Schoettle,Courtney Dubois,Kylee Jones,Peaches Ulrich,Hao Yan,Joseph N. Blattman
出处
期刊:Journal of Immunology
[American Association of Immunologists]
日期:2019-05-01
卷期号:202 (1_Supplement): 130.13-130.13
标识
DOI:10.4049/jimmunol.202.supp.130.13
摘要
Abstract Antibodies are a diverse set of glycoproteins produced by B-cells in response to antigen exposure, infection, or certain malignancies, making it crucial to develop a high throughput and robust technique to obtain paired heavy and light chain information from individual B-cells. We have developed DNA origami-based capture probes to isolate paired heavy and light sequence information from single B-cells. The capture probes are designed to hybridize with the constant regions of heavy and light chains. Each capture probe also incorporates sequences for hybridization with DNA origami nanostructures. The nanostructures can be electroporated into B-cells and re-isolated by cell lysis and streptavidin affinity purification. Heavy and light chains are then reverse transcribed, appending the isolated sequences to the capture probes. Following PCR-amplification, each amplicon will contain BCR heavy or light chain sequence, as well as a unique barcode. Matching barcodes from complementary heavy and light chain amplicons can then be paired via next-generation sequencing. We have used this technique to analyze the antibody repertoire from splenic tissue of unimmunized C57BL/6J mice. We designed a single IgM-Igk specific capture probe and synthesized DNA origami nanostructures. The nanostructures were transfected into naïve B-cells, purified, reverse transcribed, and PCR-amplified. The isolated IgM and Igk amplicons were confirmed by sequencing. Through this approach, we present a novel DNA origami-based technique for single cell paired BCR repertoire analysis. This is a highly versatile technique that can be used to isolate any gene pair functioning in cellular dynamics such as signaling pathways or co-occurring mutations in cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI